je.st
news
Amgen says version of Humira meets study goal
2014-10-09 06:22:53| Biotech - Topix.net
Amgen said Wednesday that its version of Humira, the best-selling drug in the world, worked as well as the original medication in a late-stage clinical trial. The study is one of two that Amgen is running to compare its generic biotech drug ABP 501 to Humira as a treatment for moderate to severe plaque psoriasis.
Tags: version
study
goal
meets
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||